stem-cell ageing modified cyclin-dependent kinase inhibitor p16ink4a 
stem-cell ageing thought contribute altered tissue maintenance repair older humans experience increased bone marrow failure poorer haematologic tolerance cytotoxic injury haematopoietic stem cells hscs older mice decreased per-cell repopulating activity self-renewal homing abilities myeloid skewing differentiation increased apoptosis stress report cyclin-dependent kinase inhibitor p16ink4a level previously noted increase cell types age accumulates modulates specific age-associated hsc functions notably absence p16ink4a hsc repopulating defects apoptosis mitigated improving stress tolerance cells survival animals successive transplants stem cell-autonomous tissue regeneration model inhibition p16ink4a may ameliorate physiological impact ageing stem cells thereby improve injury repair aged tissue 
